Kratom—pharmacology, clinical implications, and outlook: a comprehensive review SC Eastlack, EM Cornett, AD Kaye Pain and therapy 9, 55-69, 2020 | 156 | 2020 |
Current perspectives on the impact of Kratom use C Veltri, O Grundmann Substance abuse and rehabilitation, 23-31, 2019 | 154 | 2019 |
Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic A Garcia-Romeu, DJ Cox, KE Smith, KE Dunn, RR Griffiths Drug and alcohol dependence 208, 107849, 2020 | 122 | 2020 |
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use KE Smith, JM Rogers, D Schriefer, O Grundmann Drug and Alcohol Dependence 226, 108879, 2021 | 46 | 2021 |
Self-reported health diagnoses and demographic correlates with kratom use: results from an online survey R Bath, T Bucholz, AF Buros, D Singh, KE Smith, CA Veltri, O Grundmann Journal of addiction medicine 14 (3), 244-252, 2020 | 42 | 2020 |
Kratom use as more than a “self-treatment” KE Smith, KE Dunn, JM Rogers, O Grundmann, CR McCurdy, ... The American Journal of Drug and Alcohol Abuse 48 (6), 684-694, 2022 | 28 | 2022 |
Searching for a signal: Self-reported kratom dose-effect relationships among a sample of US adults with regular kratom use histories KE Smith, JM Rogers, KE Dunn, O Grundmann, CR McCurdy, D Schriefer, ... Frontiers in Pharmacology 13, 765917, 2022 | 23 | 2022 |